LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
17,780,491
Share change
-578,160
Total reported value
$70,939,779
Put/Call ratio
62%
Price per share
$3.99
Number of holders
51
Value change
-$2,441,335
Number of buys
15
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q3 2021

As of 30 Sep 2021, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,780,491 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, BOXER CAPITAL, LLC, VANGUARD GROUP INC, D. E. Shaw & Co., Inc., BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, HealthInvest Partners AB, and TANG KEVIN C. This page lists 51 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.